These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21845354)

  • 1. Drug therapy of post-stroke aphasia: a review of current evidence.
    Berthier ML; Pulvermüller F; Dávila G; Casares NG; Gutiérrez A
    Neuropsychol Rev; 2011 Sep; 21(3):302-17. PubMed ID: 21845354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety of Pharmacological Treatments for Post-stroke Aphasia.
    Zhang X; Shu B; Zhang D; Huang L; Fu Q; Du G
    CNS Neurol Disord Drug Targets; 2018; 17(7):509-521. PubMed ID: 29984673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First decade of research on constrained-induced treatment approaches for aphasia rehabilitation.
    Meinzer M; Rodriguez AD; Gonzalez Rothi LJ
    Arch Phys Med Rehabil; 2012 Jan; 93(1 Suppl):S35-45. PubMed ID: 22202189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of piracetam in the treatment of acute and chronic aphasia.
    Huber W
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral brain reorganization with memantine and constraint-induced aphasia therapy in chronic post-stroke aphasia: An ERP study.
    Barbancho MA; Berthier ML; Navas-Sánchez P; Dávila G; Green-Heredia C; García-Alberca JM; Ruiz-Cruces R; López-González MV; Dawid-Milner MS; Pulvermüller F; Lara JP
    Brain Lang; 2015; 145-146():1-10. PubMed ID: 25932618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment for aphasia following stroke.
    Greener J; Enderby P; Whurr R
    Cochrane Database Syst Rev; 2001; 2001(4):CD000424. PubMed ID: 11687079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia.
    Berthier ML; Green C; Lara JP; Higueras C; Barbancho MA; Dávila G; Pulvermüller F
    Ann Neurol; 2009 May; 65(5):577-85. PubMed ID: 19475666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better language through chemistry: Augmenting speech-language therapy with pharmacotherapy in the treatment of aphasia.
    Stockbridge MD
    Handb Clin Neurol; 2022; 185():261-272. PubMed ID: 35078604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine administration in chronic post-stroke aphasia.
    Hong JM; Shin DH; Lim TS; Lee JS; Huh K
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):675-80. PubMed ID: 22595363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
    Kessler J; Thiel A; Karbe H; Heiss WD
    Stroke; 2000 Sep; 31(9):2112-6. PubMed ID: 10978039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Advances to Post-Stroke Aphasia Pharmacology and Rehabilitation.
    Cichon N; Wlodarczyk L; Saluk-Bijak J; Bijak M; Redlicka J; Gorniak L; Miller E
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speech and language therapy for aphasia following stroke.
    Brady MC; Kelly H; Godwin J; Enderby P; Campbell P
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD000425. PubMed ID: 27245310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does treatment with piracetam in stroke patients with aphasia make sense?].
    Schmidtke K
    Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280
    [No Abstract]   [Full Text] [Related]  

  • 14. Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.
    Palmer R; Dimairo M; Latimer N; Cross E; Brady M; Enderby P; Bowen A; Julious S; Harrison M; Alshreef A; Bradley E; Bhadhuri A; Chater T; Hughes H; Witts H; Herbert E; Cooper C
    Health Technol Assess; 2020 Apr; 24(19):1-176. PubMed ID: 32369007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled study of donepezil in poststroke aphasia.
    Berthier ML; Green C; Higueras C; Fernández I; Hinojosa J; Martín MC
    Neurology; 2006 Nov; 67(9):1687-9. PubMed ID: 17101908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poststroke aphasia : epidemiology, pathophysiology and treatment.
    Berthier ML
    Drugs Aging; 2005; 22(2):163-82. PubMed ID: 15733022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa does not add to the success of high-intensity language training in aphasia.
    Breitenstein C; Korsukewitz C; Baumgärtner A; Flöel A; Zwitserlood P; Dobel C; Knecht S
    Restor Neurol Neurosci; 2015; 33(2):115-20. PubMed ID: 25588456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of poststroke aphasia.
    Bakheit AM
    Expert Rev Neurother; 2004 Mar; 4(2):211-7. PubMed ID: 15853562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constraint-induced aphasia therapy in post-stroke aphasia rehabilitation: A systematic review and meta-analysis of randomized controlled trials.
    Zhang J; Yu J; Bao Y; Xie Q; Xu Y; Zhang J; Wang P
    PLoS One; 2017; 12(8):e0183349. PubMed ID: 28846724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial.
    Baumgaertner A; Grewe T; Ziegler W; Floel A; Springer L; Martus P; Breitenstein C
    Trials; 2013 Sep; 14():308. PubMed ID: 24059983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.